Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

US-guided optical tomography: correlation with clinicopathologic variables in breast cancer.

Choi JS, Kim MJ, Youk JH, Moon HJ, Suh HJ, Kim EK.

Ultrasound Med Biol. 2013 Feb;39(2):233-40. doi: 10.1016/j.ultrasmedbio.2012.09.014. Epub 2012 Dec 4.

PMID:
23219038
2.

Ultrasound-guided diffuse optical tomography (DOT) of invasive breast carcinoma: does tumour total haemoglobin concentration contribute to the prediction of axillary lymph node status?

Zhu Q, Xiao M, You S, Zhang J, Jiang Y, Lai X, Dai Q.

Eur J Radiol. 2012 Nov;81(11):3185-9. doi: 10.1016/j.ejrad.2012.01.029. Epub 2012 Mar 7.

PMID:
22401751
3.

Detecting angiogenesis in breast tumors: comparison of color Doppler flow imaging with ultrasound-guided diffuse optical tomography.

Zhu Q, You S, Jiang Y, Zhang J, Xiao M, Dai Q, Sun Q.

Ultrasound Med Biol. 2011 Jun;37(6):862-9. doi: 10.1016/j.ultrasmedbio.2011.03.010. Epub 2011 Apr 30.

PMID:
21531497
4.

Early-stage invasive breast cancers: potential role of optical tomography with US localization in assisting diagnosis.

Zhu Q, Hegde PU, Ricci A Jr, Kane M, Cronin EB, Ardeshirpour Y, Xu C, Aguirre A, Kurtzman SH, Deckers PJ, Tannenbaum SH.

Radiology. 2010 Aug;256(2):367-78. doi: 10.1148/radiol.10091237. Epub 2010 Jun 22.

6.

Diffuse optical tomography of breast carcinoma: can tumor total hemoglobin concentration be considered as a new promising prognostic parameter of breast carcinoma?

Xiao M, Jiang Y, Zhu Q, You S, Li J, Wang H, Lai X, Zhang J, Liu H, Zhang J.

Acad Radiol. 2015 Apr;22(4):439-46. doi: 10.1016/j.acra.2014.12.012.

PMID:
25753593
7.

Benign versus malignant breast masses: optical differentiation with US-guided optical imaging reconstruction.

Zhu Q, Cronin EB, Currier AA, Vine HS, Huang M, Chen N, Xu C.

Radiology. 2005 Oct;237(1):57-66. Erratum in: Radiology. 2006 May;239(2):613.

8.

Assessment of Functional Differences in Malignant and Benign Breast Lesions and Improvement of Diagnostic Accuracy by Using US-guided Diffuse Optical Tomography in Conjunction with Conventional US.

Zhu Q, Ricci A Jr, Hegde P, Kane M, Cronin E, Merkulov A, Xu Y, Tavakoli B, Tannenbaum S.

Radiology. 2016 Aug;280(2):387-97. doi: 10.1148/radiol.2016151097. Epub 2016 Mar 2.

9.

Utilizing optical tomography with ultrasound localization to image heterogeneous hemoglobin distribution in large breast cancers.

Zhu Q, Kurtzma SH, Hegde P, Tannenbaum S, Kane M, Huang M, Chen NG, Jagjivan B, Zarfos K.

Neoplasia. 2005 Mar;7(3):263-70.

10.

Correlation of perfusion parameters on dynamic contrast-enhanced MRI with prognostic factors and subtypes of breast cancers.

Koo HR, Cho N, Song IC, Kim H, Chang JM, Yi A, Yun BL, Moon WK.

J Magn Reson Imaging. 2012 Jul;36(1):145-51. doi: 10.1002/jmri.23635. Epub 2012 Mar 5.

PMID:
22392859
11.

Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women.

Ferguson NL, Bell J, Heidel R, Lee S, Vanmeter S, Duncan L, Munsey B, Panella T, Orucevic A.

Breast J. 2013 Jan-Feb;19(1):22-30. doi: 10.1111/tbj.12059. Epub 2012 Dec 13.

PMID:
23240985
12.

Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.

Papantoniou V, Sotiropoulou E, Valsamaki P, Tsaroucha A, Sotiropoulou M, Ptohis N, Stipsanelli A, Dimitrakakis K, Marinopoulos S, Tsiouris S, Antsaklis A.

Breast Cancer. 2011 Oct;18(4):286-91. doi: 10.1007/s12282-009-0192-y. Epub 2010 Feb 9.

PMID:
20143189
13.

1H MR spectroscopy of invasive ductal carcinoma: correlations with FDG PET and histologic prognostic factors.

Tozaki M, Hoshi K.

AJR Am J Roentgenol. 2010 May;194(5):1384-90. doi: 10.2214/AJR.09.3431.

PMID:
20410429
14.

Organotropism and prognostic marker discordance in distant metastases of breast carcinoma: fact or fiction? A clinicopathologic analysis.

St Romain P, Madan R, Tawfik OW, Damjanov I, Fan F.

Hum Pathol. 2012 Mar;43(3):398-404. doi: 10.1016/j.humpath.2011.05.009. Epub 2011 Aug 12.

PMID:
21840040
15.

US-localized diffuse optical tomography in breast cancer: comparison with pharmacokinetic parameters of DCE-MRI and with pathologic biomarkers.

Kim MJ, Su MY, Yu HJ, Chen JH, Kim EK, Moon HJ, Choi JS.

BMC Cancer. 2016 Feb 1;16:50. doi: 10.1186/s12885-016-2086-7.

16.

US-guided diffused optical tomography: a promising functional imaging technique in breast lesions.

You SS, Jiang YX, Zhu QL, Liu JB, Zhang J, Dai Q, Liu H, Sun Q.

Eur Radiol. 2010 Feb;20(2):309-17. doi: 10.1007/s00330-009-1551-y. Epub 2009 Aug 26.

PMID:
19707770
17.

P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancer.

Turashvili G, McKinney SE, Goktepe O, Leung SC, Huntsman DG, Gelmon KA, Los G, Rejto PA, Aparicio SA.

Mod Pathol. 2011 Jan;24(1):64-81. doi: 10.1038/modpathol.2010.189. Epub 2010 Sep 17.

18.

The value of COX-2 expression in the prognostic parameters of invasive ductal carcinoma of the breast.

Barısık NO, Keser SH, Gul AE, Sensu S, Kandemir NO, Kucuk HF, Gumus M, Karadayı N.

Med Oncol. 2011 Sep;28(3):703-8. doi: 10.1007/s12032-010-9503-6. Epub 2010 Mar 31.

PMID:
20354817
19.

Multicentric mammary carcinoma: evidence of monoclonal proliferation.

Middleton LP, Vlastos G, Mirza NQ, Eva S, Sahin AA.

Cancer. 2002 Apr 1;94(7):1910-6.

20.

Prognostic significance of Bcl-2 in invasive mammary carcinomas: a comparative clinicopathologic study between "triple-negative" and non-"triple-negative" tumors.

Tawfik K, Kimler BF, Davis MK, Fan F, Tawfik O.

Hum Pathol. 2012 Jan;43(1):23-30. doi: 10.1016/j.humpath.2011.04.011. Epub 2011 Jul 20.

PMID:
21777944

Supplemental Content

Support Center